Ezra Cohen to Quality-Adjusted Life Years
This is a "connection" page, showing publications Ezra Cohen has written about Quality-Adjusted Life Years.
Connection Strength
0.043
-
Cost-effectiveness analysis of nivolumab for the treatment of squamous cell carcinoma of the head and neck in the United States. J Med Econ. 2020 May; 23(5):442-447.
Score: 0.043
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.